SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-07-025102
Filing Date
2007-12-26
Accepted
2007-12-26 06:33:53
Documents
4
Period of Report
2007-12-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS 8K 12-24-2007 form8k.htm 8-K 81939
2 EXHIBIT 10.6 ex10_6.htm EX-10.6 94085
3 EXHIBIT 10.7 ex10_7.htm EX-10.7 99536
4 EXHIBIT 10.9 ex10_9.htm EX-10.9 120658
  Complete submission text file 0001140361-07-025102.txt   397900
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50590 | Film No.: 071324840
SIC: 2834 Pharmaceutical Preparations